| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 6008 | 2020 |
| An mRNA vaccine against SARS-CoV-2—preliminary report LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ... New England journal of medicine 383 (20), 1920-1931, 2020 | 3466 | 2020 |
| Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 2539 | 2020 |
| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1761 | 2021 |
| Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ... New England Journal of Medicine 383 (25), 2427-2438, 2020 | 1600 | 2020 |
| Avian influenza A (H5N1) infection in humans Writing Committee of the World Health Organization (WHO) Consultation on ... New England Journal of Medicine 353 (13), 1374-1385, 2005 | 1528 | 2005 |
| Cecil medicine L Goldman, DA Ausiello Saunders Elsevier, 2008 | 1245 | 2008 |
| Durability of responses after SARS-CoV-2 mRNA-1273 vaccination AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ... New England Journal of Medicine 384 (1), 80-82, 2021 | 814 | 2021 |
| Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19 N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ... New England Journal of Medicine 384 (23), 2259-2261, 2021 | 693 | 2021 |
| Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 520 | 2021 |
| Homologous and heterologous Covid-19 booster vaccinations RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ... New England Journal of Medicine 386 (11), 1046-1057, 2022 | 487 | 2022 |
| A randomized, controlled trial of ZMapp for Ebola virus infection Prevail II Writing Group New England Journal of Medicine 375 (15), 1448-1456, 2016 | 480 | 2016 |
| A recombinant vesicular stomatitis virus Ebola vaccine JA Regules, JH Beigel, KM Paolino, J Voell, AR Castellano, Z Hu, ... New England Journal of Medicine 376 (4), 330-341, 2017 | 446 | 2017 |
| SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination R Pajon, NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, ... New England Journal of Medicine 386 (11), 1088-1091, 2022 | 360 | 2022 |
| Current and future antiviral therapy of severe seasonal and avian influenza J Beigel, M Bray Antiviral research 78 (1), 91-102, 2008 | 328 | 2008 |
| Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease ML Jison, PJ Munson, JJ Barb, AF Suffredini, S Talwar, C Logun, ... Blood 104 (1), 270-280, 2004 | 237 | 2004 |
| WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus HJ Schünemann, SR Hill, M Kakad, R Bellamy, TM Uyeki, FG Hayden, ... The Lancet infectious diseases 7 (1), 21-31, 2007 | 229 | 2007 |
| Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses JAS Moser, A Galindo‐Fraga, AA Ortiz‐Hernández, W Gu, S Hunsberger, ... Influenza and other respiratory viruses 13 (1), 3-9, 2019 | 198 | 2019 |
| Hark back: passive immunotherapy for influenza and other serious infections TC Luke, A Casadevall, SJ Watowich, SL Hoffman, JH Beigel, TH Burgess Critical care medicine 38, e66-e73, 2010 | 192 | 2010 |
| Recommendations for intensive care unit and hospital preparations for an influenza epidemic or mass disaster: summary report of the European Society of Intensive Care Medicine … CL Sprung, JL Zimmerman, MD Christian, GM Joynt, JL Hick, B Taylor, ... Intensive care medicine 36, 428-443, 2010 | 192 | 2010 |
